Appello Pharmaceuticals
Nashville, US · Founded 2017 · Delaware corporation · 3 known investors
Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases. The company leverages scientific expertise and infrastructure to advance novel therapeutics through preclinical and clinical development.
Founders & leadership
Appello Pharmaceuticals was founded in 2017 by Dr. Laden.
DL
Dr. LadenCo-founder
CR
Christopher RandNamed on SEC filing
VB
Vaughn BrysonNamed on SEC filing
JP
Jeff P. ConnNamed on SEC filing
Board
WS
William SlatteryBoard director
HF
JC
Joseph Cook, Jr.Board director
Investors · 3
Reported raises · per SEC filings
Form D private placements$29M disclosed across 2 rounds · 2018–2022
▶$13.5MraisedJan 2022 · 9 investors · PharmaceuticalsRule 506(b)
▶$13.5MraisedJan 2022 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Vaughn BrysonDirector
- Howard FurstDirector
- Christopher RandExecutive Officer
- Joseph Cook, Jr.Director
- Brian LadenExecutive Officer, Director
- William SlatteryDirector
- Jeff P. ConnDirector
- Offering amount
- $13.5M
- Amount sold
- $13.5M
- Minimum investment
- $1
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$15.5MraisedNov 2020 · 5 investors · Other Health CareRule 506(b)
▶$15.5MraisedNov 2020 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Christopher RandExecutive Officer
- William SlatteryDirector
- Brian LadenExecutive Officer, Director
- Howie FurstDirector
- Vaughn BrysonDirector
- Joseph Cook, Jr.Director
- Jeff P. ConnDirector
- Offering amount
- $15.6M
- Amount sold
- $15.5M
- Minimum investment
- $1
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Appello Pharmaceuticals do?
- Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases. The company leverages scientific expertise and infrastructure to advance novel therapeutics through preclinical and clinical development.
- Who founded Appello Pharmaceuticals?
- Appello Pharmaceuticals was founded by Dr. Laden in 2017.
- Who are Appello Pharmaceuticals's investors?
- Appello Pharmaceuticals's investors include Mountain Group Capital, Relevance Ventures, Deerfield Management Company.
- How much funding has Appello Pharmaceuticals raised?
- Appello Pharmaceuticals has disclosed $29M raised across 2 rounds.
- Where is Appello Pharmaceuticals headquartered?
- Appello Pharmaceuticals is headquartered in Nashville, US.